Congcong Guo

1.0k total citations · 1 hit paper
38 papers, 662 citations indexed

About

Congcong Guo is a scholar working on Molecular Biology, Surgery and Nephrology. According to data from OpenAlex, Congcong Guo has authored 38 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Surgery and 5 papers in Nephrology. Recurrent topics in Congcong Guo's work include Chronic Kidney Disease and Diabetes (4 papers), Tissue Engineering and Regenerative Medicine (3 papers) and Celiac Disease Research and Management (3 papers). Congcong Guo is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Tissue Engineering and Regenerative Medicine (3 papers) and Celiac Disease Research and Management (3 papers). Congcong Guo collaborates with scholars based in China, United States and Hong Kong. Congcong Guo's co-authors include Chunxia Jing, Guang Yang, Meiling Ou, Di Xiao, Lin Liao, Zixing Zhou, Dandan Liu, Yajing Han, Shiqi Huang and Zihao Wen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Catalysis B: Environmental and Scientific Reports.

In The Last Decade

Congcong Guo

33 papers receiving 647 citations

Hit Papers

Global Epidemiology of Dengue Outbreaks in 1990–2015: A S... 2017 2026 2020 2023 2017 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Congcong Guo China 12 262 160 158 59 57 38 662
Riyadh Saif-Ali Yemen 15 204 0.8× 62 0.4× 121 0.8× 27 0.5× 37 0.6× 41 734
Dan Năvolan Romania 18 67 0.3× 62 0.4× 160 1.0× 102 1.7× 19 0.3× 75 691
Raul Aguilar Schall United States 15 76 0.3× 130 0.8× 142 0.9× 33 0.6× 94 1.6× 24 2.6k
Arifa Nazneen Japan 14 77 0.3× 80 0.5× 227 1.4× 31 0.5× 35 0.6× 34 753
P. Krishnamurthy India 11 62 0.2× 111 0.7× 145 0.9× 18 0.3× 26 0.5× 34 620
Provash Chandra Sadhukhan India 14 76 0.3× 110 0.7× 141 0.9× 66 1.1× 34 0.6× 53 563
Rong Tang China 19 331 1.3× 115 0.7× 185 1.2× 116 2.0× 64 1.1× 50 1.1k
Helena Kollárová Czechia 19 76 0.3× 34 0.2× 349 2.2× 22 0.4× 157 2.8× 50 1.0k
Qi Zheng China 18 88 0.3× 109 0.7× 223 1.4× 93 1.6× 103 1.8× 58 912
Nawal Helmi Saudi Arabia 11 43 0.2× 172 1.1× 129 0.8× 91 1.5× 25 0.4× 40 643

Countries citing papers authored by Congcong Guo

Since Specialization
Citations

This map shows the geographic impact of Congcong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Congcong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Congcong Guo more than expected).

Fields of papers citing papers by Congcong Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Congcong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Congcong Guo. The network helps show where Congcong Guo may publish in the future.

Co-authorship network of co-authors of Congcong Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Congcong Guo. A scholar is included among the top collaborators of Congcong Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Congcong Guo. Congcong Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Haotian, et al.. (2025). The NIMA-related kinase family and cancer. Frontiers in Oncology. 15. 1556917–1556917. 1 indexed citations
3.
Pan, Jingwen, Xinyuan Wang, Congcong Guo, et al.. (2024). Insights into the enhanced oxidation of organic micropollutants by single-atom Cu catalyst activated peroxydisulfate: Valence-dominated nonradical pathway. Applied Catalysis B: Environmental. 351. 123997–123997. 36 indexed citations
4.
Guo, Congcong, et al.. (2024). Crosstalk between proximal tubular epithelial cells and other interstitial cells in tubulointerstitial fibrosis after renal injury. Frontiers in Endocrinology. 14. 1256375–1256375. 19 indexed citations
5.
Yu, Chao, Congcong Guo, Yiran Zhang, et al.. (2024). Hitting two birds with one stone: A ce-modified Fe-based bi-functional material reinforced fenton-like system for complete removal of organophosphorus pesticides. Chemical Engineering Journal. 497. 154828–154828. 9 indexed citations
6.
Guo, Congcong, et al.. (2024). High CD133 expression in proximal tubular cells in diabetic kidney disease: good or bad?. Journal of Translational Medicine. 22(1). 159–159. 2 indexed citations
9.
Guo, Congcong, et al.. (2024). Claudin-2 Mediates the Proximal Tubular Epithelial Cell–Fibroblast Crosstalk via Paracrine CTGF. Diabetes Metabolic Syndrome and Obesity. Volume 17. 55–73. 5 indexed citations
11.
Li, Wei, Zhe Li, Congcong Guo, et al.. (2023). No evidence of genetic causality between diabetes and osteonecrosis: a bidirectional two-sample Mendelian randomization analysis. Journal of Orthopaedic Surgery and Research. 18(1). 970–970.
12.
Wang, Xun, et al.. (2023). An integrated computational strategy to predict personalized cancer drug combinations by reversing drug resistance signatures. Computers in Biology and Medicine. 163. 107230–107230. 10 indexed citations
13.
Guo, Congcong, Yubo Ma, Li Liu, et al.. (2023). Mesenchymal stem cells therapy improves ovarian function in premature ovarian failure: a systematic review and meta-analysis based on preclinical studies. Frontiers in Endocrinology. 14. 1165574–1165574. 13 indexed citations
14.
Li, Chunyan, et al.. (2020). Effect of Yugengtongyu Granules in Patients with Stable Coronary Artery Disease on Reducing Adverse Cardiovascular Events: A Double-Blind Controlled Trial. The Journal of Alternative and Complementary Medicine. 27(2). 142–149. 4 indexed citations
15.
Liu, Hongxuan, Baohuan Zhang, Xiaoqian Zou, et al.. (2019). Identification of genetic variations in Necator americanus through resequencing by whole genome amplification. Journal of International Medical Research. 47(9). 4353–4364. 1 indexed citations
16.
Guo, Congcong, Yun Li, Rui Zhang, et al.. (2018). Protective Effect of Salidroside Against Diabetic Kidney Disease Through Inhibiting BIM-Mediated Apoptosis of Proximal Renal Tubular Cells in Rats. Frontiers in Pharmacology. 9. 1433–1433. 29 indexed citations
17.
18.
Guo, Congcong, Zixing Zhou, Zihao Wen, et al.. (2017). Global Epidemiology of Dengue Outbreaks in 1990–2015: A Systematic Review and Meta-Analysis. Frontiers in Cellular and Infection Microbiology. 7. 317–317. 283 indexed citations breakdown →
19.
Yang, Guang, Baohuan Zhang, Na Zhang, et al.. (2015). Systematic review and meta-analysis of the association between IL18RAP rs917997 and CCR3 rs6441961 polymorphisms with celiac disease risks. Expert Review of Gastroenterology & Hepatology. 9(10). 1327–1338. 2 indexed citations
20.
Staessen, Jan A., A. Amery, D Clément, et al.. (1992). Twenty-four hour blood pressure monitoring in the Syst-Eur trial. Aging Clinical and Experimental Research. 4(1). 85–91. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026